Table 1. Clinical characteristic of lymphoepithelioma-like cholangiocarcinoma.
Case | Age (year) | Sex | Tumor site | Tumor size (cm) | HBV | HCV | EBER | AFP (ng/ml) | CA199 (u/ml) | Clinical outcome |
---|---|---|---|---|---|---|---|---|---|---|
1 | 60 | M | Right lobe | 6.0 | + | − | + | 2.1 | 1.1 | DOD, 27 months follow-up |
2 | 53 | M | Right lobe | 2.4 | − | − | + | 2.7 | 23.1 | DOD, 22 months follow-up |
3 | 39 | M | Left lobe | 2.0 | − | − | − | 3.0 | 7.6 | AWOD, 54 months follow-up |
4 | 43 | F | Right lobe | 1.2 | − | − | + | 2.3 | 7.4 | AWOD, 51 months follow-up |
5 | 62 | M | Right lobe | 3.2 | + | − | − | 4.7 | 36.0 | AWOD, 37 months follow-up |
6 | 65 | F | Right lobe | 5.0 | + | − | − | 42.4 | 21.0 | AWOD, 37 months follow-up |
7 | 47 | F | Left lobe | 1.9 | − | − | + | 1.9 | 2.7 | AWOD, 35 months follow-up |
8 | 52 | M | Right lobe | 1.9 | + | − | − | 1.3 | 9.8 | AWOD, 19 months follow-up |
9 | 60 | M | Left lobe | 2.6 | − | − | + | 1.5 | 15.5 | AWOD, 12 months follow-up |
10 | 61 | M | Right lobe | 2.4 | + | − | − | 3.8 | 14.7 | AWD, 12 months follow-up Intrahepatic recurrence (10 months) |
11 | 35 | M | Right lobe | 3.1 | + | − | + | 3.3 | 13.1 | AWOD, 10 months follow-up |
12 | 48 | M | Right lobe | 3.5 | − | − | + | 1.4 | 3.5 | AWOD, 9 months follow-up |
13 | 71 | F | Right lobe | 2.2 | − | − | + | 1.7 | 4.0 | AWOD, 8 months follow-up |
AWOD, Alive without disease; AWD, alive with disease; DOD, died of disease.